These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17043678)

  • 1. Reduced semen quality in chronic prostatitis patients that induce the release of apoptotic protein Omi/HtrA2 from spermatozoa.
    Hu XY; Xu YM; Qiao Y; Wu DL; Sa YL; Fu Q; Yu JJ; Zhang XR; Zhang J; Gu BJ; Chen R; Xie H
    Prostate Cancer Prostatic Dis; 2007; 10(1):104-8. PubMed ID: 17043678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of Omi/HtrA2 UP-regulated in the spermatozoa of chronic bacterial prostatitis patients].
    Hu XY; Xu YM; Qiao Y; Liu ZS; Song LJ; Li C
    Zhonghua Nan Ke Xue; 2008 Jan; 14(1):47-50. PubMed ID: 18297812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced semen quality in chronic prostatitis patients that have cellular autoimmune response to prostate antigens.
    Motrich RD; Maccioni M; Molina R; Tissera A; Olmedo J; Riera CM; Rivero VE
    Hum Reprod; 2005 Sep; 20(9):2567-72. PubMed ID: 15890732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways.
    Suzuki Y; Takahashi-Niki K; Akagi T; Hashikawa T; Takahashi R
    Cell Death Differ; 2004 Feb; 11(2):208-16. PubMed ID: 14605674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Akt attenuation of the serine protease activity of HtrA2/Omi through phosphorylation of serine 212.
    Yang L; Sun M; Sun XM; Cheng GZ; Nicosia SV; Cheng JQ
    J Biol Chem; 2007 Apr; 282(15):10981-7. PubMed ID: 17311912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced semen quality caused by chronic abacterial prostatitis: an enigma or reality?
    Leib Z; Bartoov B; Eltes F; Servadio C
    Fertil Steril; 1994 Jun; 61(6):1109-16. PubMed ID: 8194626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omi/HtrA2 Regulates a Mitochondria-Dependent Apoptotic Pathway in a Murine Model of Septic Encephalopathy.
    Wang P; Hu Y; Yao D; Li Y
    Cell Physiol Biochem; 2018; 49(6):2163-2173. PubMed ID: 30286467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of AIF and HtrA2/Omi in small lymphocytic lymphoma and diffuse large B-cell lymphoma.
    Li S; Wan M; Cao X; Ren Y
    Arch Pathol Lab Med; 2011 Jul; 135(7):903-8. PubMed ID: 21732781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of Omi/HtrA2 expression in prostate cancer and benign prostatic hyperplasia.
    Hu XY; Xu YM; Chen XC; Ping H; Chen ZH; Zeng FQ
    APMIS; 2006 Dec; 114(12):893-8. PubMed ID: 17207090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of Omi/HtrA2 on expression of anti-apoptotic protein PED/PEA-15 and apoptosis of prostate cancer cell line PC-3].
    Hu XY; Chen XC; Zhu ZH; Chen CH; Zeng FQ; Lu GC
    Ai Zheng; 2006 Jun; 25(6):677-82. PubMed ID: 16764760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion.
    Althaus J; Siegelin MD; Dehghani F; Cilenti L; Zervos AS; Rami A
    Neurochem Int; 2007 Jan; 50(1):172-80. PubMed ID: 16978742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of Omi/HtrA2 expression in stomach cancer.
    Lee SH; Lee JW; Kim HS; Kim SY; Park WS; Kim SH; Lee JY; Yoo NJ
    APMIS; 2003 May; 111(5):586-90. PubMed ID: 12887511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omi/HtrA2 pro-apoptotic marker differs in various hepatocellular carcinoma cell lines owing to ped/pea-15 expression level.
    Xu Z; Chen Y; Xu G; Peng C; Liu E; Li Y; Niu J; Li C
    Oncol Rep; 2015 Feb; 33(2):905-12. PubMed ID: 25484138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2.
    Srinivasula SM; Gupta S; Datta P; Zhang Z; Hegde R; Cheong N; Fernandes-Alnemri T; Alnemri ES
    J Biol Chem; 2003 Aug; 278(34):31469-72. PubMed ID: 12835328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation of the serine protease Omi/HtrA2 from mitochondria into the cytosol upon seizure-induced hippocampal injury in the neonatal rat brain.
    Rami A; Kim M; Niquet J
    Neurochem Res; 2010 Dec; 35(12):2199-207. PubMed ID: 21132459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omi/HtrA2 and XIAP are components of platelet apoptosis signalling.
    Winkler J; Rand ML; Schmugge M; Speer O
    Thromb Haemost; 2013 Mar; 109(3):532-9. PubMed ID: 23306356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death.
    Balakrishnan MP; Cilenti L; Mashak Z; Popat P; Alnemri ES; Zervos AS
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H643-53. PubMed ID: 19502560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi.
    Li W; Srinivasula SM; Chai J; Li P; Wu JW; Zhang Z; Alnemri ES; Shi Y
    Nat Struct Biol; 2002 Jun; 9(6):436-41. PubMed ID: 11967569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells.
    Pruefer FG; Lizarraga F; Maldonado V; Melendez-Zajgla J
    J Chemother; 2008 Jun; 20(3):348-54. PubMed ID: 18606591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of mitochondrial function and morphology by interaction of Omi/HtrA2 with the mitochondrial fusion factor OPA1.
    Kieper N; Holmström KM; Ciceri D; Fiesel FC; Wolburg H; Ziviani E; Whitworth AJ; Martins LM; Kahle PJ; Krüger R
    Exp Cell Res; 2010 Apr; 316(7):1213-24. PubMed ID: 20064504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.